ADMA Biologics, Inc

(NASDAQ:ADMA)

Latest On ADMA Biologics, Inc (ADMA):

Date/Time Type Description Signal Details
2023-05-11 01:31 ESTNewsADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59MN/A
2023-05-11 01:30 ESTNewsADMA Biologics, Inc. (ADMA) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 23:31 ESTNewsADMA Biologics Q1 2023 Earnings PreviewN/A
2023-03-30 00:16 ESTNewsADMA Biologics: Growth Trends Pointing To ProfitabilityN/A
2023-03-24 06:16 ESTNewsADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88MN/A
2023-03-24 06:16 ESTNewsADMA Biologics expects first-time positive EBITDA by second half of yearN/A
2023-03-24 06:15 ESTNewsADMA Biologics, Inc. (ADMA) Q4 2022 Earnings Call TranscriptN/A
2023-03-22 23:00 ESTNewsADMA Biologics Q4 2022 Earnings PreviewN/A
2023-02-08 18:02 ESTNewsADMA Biocenters receives FDA approval for eighth plasma collection centerN/A
2023-01-17 17:02 ESTNewsADMA Biologics gains as guidance exceeds consensusN/A
2023-01-15 06:00 ESTNewsADMA Biologics: FY22 Numbers Key Inflection PointN/A
2022-12-13 19:01 ESTNewsAdma gets FDA approval for room temperature storage of Asceniv, BivigamN/A
2022-12-08 03:17 ESTNewsADMA Biologics stock dips after pricing ~$60M share offeringN/A
2022-12-07 07:16 ESTNewsADMA Biologics down 7% following stock offeringN/A
2022-11-11 05:31 ESTNewsADMA Biologics hits 52-week high after strong Q3 beatN/A
2022-11-09 19:31 ESTNewsADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61MN/A
2022-11-09 19:30 ESTNewsADMA Biologics, Inc. (ADMA) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 01:31 ESTNewsADMA Biologics Q3 2022 Earnings PreviewN/A
2022-10-31 13:46 ESTNewsAdma stock rises on FDA approval of North Carolina-based plasma collection centerN/A
2022-10-24 18:01 ESTNewsAdma Biologics: Understanding The Risks Of Blood Plasma CollectionN/A
2022-08-22 16:50 ESTNewsADMA Biologics: Strong Growth Is Clearing The Path To ProfitabilityN/A
2022-08-11 22:17 ESTNewsADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 22:16 ESTNewsAdma stock rises 10% after Q2 revenue nearly doubles, net loss narrowsN/A
2022-08-11 05:31 ESTNewsADMA Biologics GAAP EPS of -$0.07, revenue of $33.9MN/A
2022-08-11 05:30 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 17:45 ESTNewsADMA Biologics Q2 2022 Earnings PreviewN/A
2022-06-27 23:02 ESTNewsADMA's 6th plasma collection facility gets FDA approvalN/A
2022-06-21 22:02 ESTNewsADMA biologics to enter Russell 2000 indexN/A
2022-05-13 06:31 ESTNewsADMA Biologics: A Path To Profits Looks ClearN/A
2022-05-12 11:47 ESTNewsADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 18:00 ESTNewsADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95MN/A
2022-05-11 18:00 ESTNewsADMA Biologics up 4% after increasing 2022 revenue guidanceN/A
2022-05-10 22:45 ESTNewsADMA Biologics Q1 2022 Earnings PreviewN/A
2022-04-19 02:16 ESTNewsADMA: Pertinent UpdatesN/A
2022-04-04 13:21 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-29 21:17 ESTNewsADMA Biologics' 2021 Numbers Showed Continued Strong ExecutionN/A
2022-03-25 12:19 ESTNewsADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61MN/A
2022-03-25 12:19 ESTNewsADMA Biologics up in after-hours trading following quarterly top and bottom line beatsN/A
2022-03-25 12:18 ESTNewsADMA Biologics gets FDA approval to extend shelf life of Asceniv, BivigamN/A
2022-03-24 02:33 ESTNewsADMA Biologics Q4 2021 Earnings PreviewN/A
2022-02-10 22:16 ESTNewsAdma Biologics activist said to support strategic reviewN/A
2022-01-19 08:15 ESTNewsADMA biologics expects record preliminary 4Q and FY21 revenues to be above the consensusN/A
2022-01-18 16:46 ESTNewsADMA Biologics wins FDA nod for its fourth plasma collection centerN/A
2022-01-18 16:46 ESTNewsADMA Biologics: 2021 Was ToughN/A
2021-12-28 22:16 ESTNewsFDA updates EUA for COVID convalescent plasma limiting use to certain patientsN/A
2021-12-09 15:17 ESTNewsADMA Biologics secures new European patent related to S. pneumonia infectionsN/A
2021-11-20 23:16 ESTNewsADMA Biologics: Turning A CornerN/A
2021-11-11 20:31 ESTNewsADMA Biologics raised to Strong Buy at Raymond James citing financial momentumN/A
2021-11-11 00:15 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 01:31 ESTNewsADMA Biologics Q3 2021 Earnings PreviewN/A

About ADMA Biologics, Inc (ADMA):

ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.

See Advanced Chart

General

  • Name ADMA Biologics, Inc
  • Symbol ADMA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 313
  • Fiscal Year EndDecember
  • IPO Date2013-10-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.admabiologics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 5.32
  • Price/Book (Most Recent Quarter) 3.7
  • Enterprise Value Revenue 7.55
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.17
  • Profit Margin -166%
  • Operating Margin -138%
  • Return on Assets -21%
  • Return on Equity -124%
  • Revenue 40.3 million
  • Earnings Per Share -$1.24
  • Revenue Per Share $0.53
  • Gross Profit -10155155
  • Quarterly Earnings Growth 42.3%
View More

Highlights

  • Market Capitalization 195.71 million
  • EBITDA -52103768
  • Analyst Target Price $8.83
  • Book Value Per Share $0.80
View More

Share Statistics

  • Shares Outstanding 94.55 million
  • Shares Float 76.07 million
  • % Held by Insiders 213%
  • % Held by Institutions 54.51%
  • Shares Short 8.18 million
  • Shares Short Prior Month 8.75 million
  • Short Ratio 1.91
  • Short % of Float 12%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.7
  • 52 Week High $4.2
  • 52 Week Low $1.73
  • 50 Day Moving Average 2.42
  • 200 Day Moving Average 2.23
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ADMA Biologics, Inc (ADMA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ADMA Biologics, Inc (ADMA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$N/A-$0.19-$0.204.04%
2020-06-302020-08-05$N/A-$0.23-$0.16-42.24%
2020-03-312020-05-06$N/A-$0.26-$0.11-128.07%
2019-12-312020-03-12$12.04 million-$0.18-$0.18-0.95%
2019-09-302019-11-06$7.22 million-$0.19-$0.2315.56%
2019-06-302019-08-08$6.56 million-$0.25-$0.2914.65%
2019-03-312019-05-08$3.53 million-$0.28-$0.3211.39%
2018-12-312019-03-13$4.06 million-$0.39-$0.33-17.15%
2018-09-302018-11-08$4.23 million-$0.33-$0.31-6.45%
2018-06-302018-08-10$4.66 million-$0.35-$0.31-11.86%
2018-03-312018-05-14$4.04 million-$0.39-$0.31-26.83%
2017-12-312018-03-05$12 million-$0.24-$0.3938.46%
2017-09-302017-11-03$4.73 million-$0.59-$0.50-18.59%
2017-06-302017-08-11$3.4 million-$0.55-$0.30-84.87%
2017-03-312017-05-12$2.63 million-$0.51-$0.28-80.53%
2016-12-312017-02-24$3.33 million-$0.34-$0.32-5.59%
2016-09-302016-11-10$2.94 million-$0.34-$0.4117.87%
2016-06-302016-08-12$2.27 million-$0.50-$0.38-30.89%
2016-03-312016-05-13$2.12 million-$0.43-$0.442.82%
2015-12-312016-03-23$2.51 million-$0.44-$0.452.22%
2015-09-302015-11-10$1.85 million-$0.48-$0.39-23.08%
2015-06-302015-08-11$1.31 million-$0.44-$0.35-25.71%
2015-03-312015-05-12$1.5 million-$0.37-$0.382.63%
2014-12-312015-03-09$1.49 million-$0.38-$0.380%
2014-09-302014-11-10$1.37 million-$0.36-$0.372.7%
2014-06-302014-08-11$1.5 million-$0.43-$0.5217.31%
2014-03-312014-05-12$1.56 million-$0.64-$0.49-30.61%
2013-12-312014-03-28$425000-$0.54-$0.47-14.89%
2013-09-302013-11-12$1.11 million-$0.29

ADMA Biologics, Inc (ADMA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ADMA Biologics, Inc (ADMA) Chart:

ADMA Biologics, Inc (ADMA) News:

Below you will find a list of latest news for ADMA Biologics, Inc (ADMA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ADMA Biologics, Inc (ADMA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-07-1710CALL0 10TRUE00
2026-07-1720CALL0 00TRUE00
2026-07-1730CALL0 10TRUE00
2026-07-1740CALL0 80TRUE00
2026-07-1753.6CALL2 280TRUE3.60
2026-07-1762.75CALL0 24104.1TRUE00
2026-07-1771.6CALL0 195.52TRUE00
2026-07-1780.95CALL0 6874.43TRUE00
2026-07-1790.45CALL19 52456.07FALSE0.060.15
2026-07-17100.1CALL92 23347.94FALSE-0.01-0.09
2026-07-17110.05CALL2 12562.33FALSE00
2026-07-17120CALL0 079FALSE00
2026-07-17130CALL0 093.57FALSE00
2026-07-17140.1CALL0 1106.55FALSE00
2026-07-17150.1CALL2 0218.54FALSE0.10
2026-07-17160CALL0 0236.48FALSE00
2026-07-17170CALL0 0200.02FALSE00
2026-07-1710PUT0 0619.99FALSE00
2026-07-1720PUT0 0900.89FALSE00
2026-07-1730.05PUT1 1304.75FALSE0.050
2026-07-1740.05PUT1 1158.39FALSE0.050
2026-07-1750PUT0 0174.64FALSE00
2026-07-1760PUT0 1140.34FALSE00
2026-07-1770.1PUT1 92391.96FALSE0.020.25
2026-07-1780.25PUT101 201544.37FALSE-0.02-0.07
2026-07-1790PUT0 242160TRUE00
2026-07-17101.62PUT2 6123.06TRUE-0.1-0.06
2026-07-17110PUT0 1102.34TRUE00
2026-07-17120PUT0 00TRUE00
2026-07-17130PUT0 0150.52TRUE00
2026-07-17140PUT0 00TRUE00
2026-07-17150PUT0 0122.53TRUE00
2026-07-17160PUT0 0151.59TRUE00
2026-07-17170PUT0 1144.27TRUE00
2026-08-2110CALL0 30TRUE00
2026-08-2120CALL0 00TRUE00
2026-08-2130CALL0 00TRUE00
2026-08-2140CALL0 00TRUE00
2026-08-2150CALL0 059.29TRUE00
2026-08-2160CALL0 6286.17TRUE00
2026-08-2171.9CALL0 29112.23TRUE00
2026-08-2181.13CALL0 5941.64TRUE00
2026-08-2190.75CALL1 15370.79FALSE-0.05-0.06
2026-08-21100.4CALL18 40865.56FALSE-0.02-0.05
2026-08-21110.35CALL2 268863.62FALSE0.10.4
2026-08-21120CALL0 32179.64FALSE00
2026-08-21130CALL0 109885.83FALSE00
2026-08-21140CALL0 2367.56FALSE00
2026-08-21150.05CALL0 14681.13FALSE00
2026-08-21160.05CALL0 257888.3FALSE00
2026-08-21170.05CALL0 147288.18FALSE00
2026-08-21180CALL0 151100.96FALSE00
2026-08-21190CALL0 799.42FALSE00
2026-08-21200CALL0 552143.47FALSE00
2026-08-21210.2CALL0 18123.07FALSE00
2026-08-21220CALL0 21113.74FALSE00
2026-08-21230CALL0 11189.91FALSE00
2026-08-21240CALL0 2122FALSE00
2026-08-21250CALL0 6140.81FALSE00
2026-08-21260CALL0 0212.34FALSE00
2026-08-21270CALL0 5216.75FALSE00
2026-08-21300CALL0 3205.74FALSE00
2026-08-2110PUT0 00FALSE00
2026-08-2120PUT0 0380.99FALSE00
2026-08-2130PUT0 0386.12FALSE00
2026-08-2140PUT0 0154.29FALSE00
2026-08-2150.05PUT0 5234.71FALSE00
2026-08-2160PUT0 2539172.88FALSE00
2026-08-2170PUT0 1588.92FALSE00
2026-08-2180.6PUT0 9263.2FALSE00
2026-08-2190PUT0 568107.88TRUE00
2026-08-21101.9PUT0 13756.93TRUE00
2026-08-21110PUT0 22651.53TRUE00
2026-08-21120PUT0 360TRUE00
2026-08-21130PUT0 4582.02TRUE00
2026-08-21140PUT0 10TRUE00
2026-08-21150PUT0 093.67TRUE00
2026-08-21160PUT0 391.4TRUE00
2026-08-21170PUT0 22131.1TRUE00
2026-08-21180PUT0 0105.13TRUE00
2026-08-21190PUT0 0122.74TRUE00
2026-08-21200PUT0 0128.84TRUE00
2026-08-21210PUT0 1134.59TRUE00
2026-08-21220PUT0 0140.02TRUE00
2026-08-21230PUT0 1145.19TRUE00
2026-08-21240PUT0 1150.1TRUE00
2026-08-21250PUT0 0154.79TRUE00
2026-08-21260PUT0 0159.27TRUE00
2026-08-21270PUT0 0163.56TRUE00
2026-08-21300PUT0 0175.49TRUE00
2026-11-2010CALL0 40TRUE00
2026-11-2020CALL0 00TRUE00
2026-11-2030CALL0 00TRUE00
2026-11-2040CALL0 0121.34TRUE00
2026-11-2053.55CALL0 2096.8TRUE00
2026-11-2060CALL0 090.78TRUE00
2026-11-2072.68CALL2 1523.25TRUE2.680
2026-11-2082.68CALL1 5100.68TRUE2.680
2026-11-2091.34CALL1 10845.16FALSE-0.06-0.04
2026-11-20101.14CALL6 7677.73FALSE0.240.27
2026-11-20110.75CALL0 1304567.12FALSE00
2026-11-20120.53CALL20 3161.95FALSE-0.02-0.04
2026-11-20130CALL0 410776.69FALSE00
2026-11-20140CALL0 55875.63FALSE00
2026-11-20150CALL0 95458.61FALSE00
2026-11-20160CALL0 3003115.83FALSE00
2026-11-20170CALL0 292.74FALSE00
2026-11-20180CALL0 20777.08FALSE00
2026-11-20190.18CALL1 695.14FALSE0.180
2026-11-20200CALL0 1099.11FALSE00
2026-11-20210CALL0 288.22FALSE00
2026-11-20220CALL0 196.2FALSE00
2026-11-20230CALL0 0109.61FALSE00
2026-11-20240CALL0 0112.72FALSE00
2026-11-20250CALL0 11105.15FALSE00
2026-11-2010PUT0 0382.84FALSE00
2026-11-2020PUT0 0240.31FALSE00
2026-11-2030PUT0 0162.03FALSE00
2026-11-2040.11PUT0 5135.57FALSE00
2026-11-2050.15PUT0 11115.88FALSE00
2026-11-2060.5PUT1 303978.17FALSE0.50
2026-11-2070.72PUT0 12584.98FALSE00
2026-11-2081.1PUT0 554163.41FALSE00
2026-11-2090PUT0 3989.08TRUE00
2026-11-20100PUT0 10068.49TRUE00
2026-11-20110PUT0 1249.57TRUE00
2026-11-20120PUT0 1563.32TRUE00
2026-11-20130PUT0 240TRUE00
2026-11-20140PUT0 200TRUE00
2026-11-20150PUT0 158.7TRUE00
2026-11-20160PUT0 078.7TRUE00
2026-11-20170PUT0 168.93TRUE00
2026-11-20180PUT0 00TRUE00
2026-11-20190PUT0 077.83TRUE00
2026-11-20200PUT0 088.5TRUE00
2026-11-20210PUT0 092.47TRUE00
2026-11-20220PUT0 096.23TRUE00
2026-11-20230PUT0 099.81TRUE00
2026-11-20240PUT0 0103.22TRUE00
2026-11-20250PUT0 0106.49TRUE00
2027-01-1535.85CALL0 21495.03TRUE00
2027-01-1550CALL0 5278.61TRUE00
2027-01-1560CALL0 192.39TRUE00
2027-01-1570CALL0 8269.36TRUE00
2027-01-1580CALL0 14177.47TRUE00
2027-01-1591.72CALL1 5773.74FALSE1.720
2027-01-15101.35CALL3 95189.71FALSE0.10.08
2027-01-15110CALL0 1862.59FALSE00
2027-01-15120CALL0 2456.73FALSE00
2027-01-15130.5CALL0 223362.66FALSE00
2027-01-15140CALL0 4177.78FALSE00
2027-01-15150CALL0 137259.85FALSE00
2027-01-15160CALL0 5674.26FALSE00
2027-01-15170.2CALL0 64673.15FALSE00
2027-01-15200.17CALL11 390669.82FALSE0.170
2027-01-15220CALL0 55575.48FALSE00
2027-01-15250CALL0 71998.31FALSE00
2027-01-15270CALL0 346978.62FALSE00
2027-01-15300CALL0 57190.29FALSE00
2027-01-15320CALL0 2293.71FALSE00
2027-01-15350CALL0 16698.39FALSE00
2027-01-15370CALL0 44104.05FALSE00
2027-01-1530PUT0 0163.39FALSE00
2027-01-1550PUT0 17101.4FALSE00
2027-01-1560PUT0 479.78FALSE00
2027-01-1570PUT0 1363.41FALSE00
2027-01-1580PUT0 12379.42FALSE00
2027-01-1590PUT0 18283.1TRUE00
2027-01-15100PUT0 9459.69TRUE00
2027-01-15110PUT0 058.76TRUE00
2027-01-15120PUT0 047.22TRUE00
2027-01-15130PUT0 108158.27TRUE00
2027-01-15140PUT0 062.01TRUE00
2027-01-15150PUT0 34561.42TRUE00
2027-01-15160PUT0 00TRUE00
2027-01-15170PUT0 4562.05TRUE00
2027-01-15200PUT0 00TRUE00
2027-01-15220PUT0 086.08TRUE00
2027-01-15250PUT0 095.24TRUE00
2027-01-15270PUT0 0100.71TRUE00
2027-01-15300PUT0 0108.17TRUE00
2027-01-15320PUT0 0112.75TRUE00
2027-01-15350PUT0 0119.08TRUE00
2027-01-15370PUT0 0123TRUE00
2027-02-1910CALL0 0143.64TRUE00
2027-02-1920CALL0 081.19TRUE00
2027-02-1930CALL0 085.86TRUE00
2027-02-1940CALL0 00TRUE00
2027-02-1950CALL0 069.56TRUE00
2027-02-1960CALL0 063.6TRUE00
2027-02-1970CALL0 070.34TRUE00
2027-02-1980CALL0 073.09TRUE00
2027-02-1990CALL0 075.1FALSE00
2027-02-19100CALL0 081.65FALSE00
2027-02-19110CALL0 067.41FALSE00
2027-02-19120CALL0 069.23FALSE00
2027-02-19130CALL0 065.72FALSE00
2027-02-19140CALL0 080.37FALSE00
2027-02-19150CALL0 070.63FALSE00
2027-02-19160CALL0 073.05FALSE00
2027-02-19170CALL0 072.5FALSE00
2027-02-1910PUT0 0303.78FALSE00
2027-02-1920PUT0 0174.43FALSE00
2027-02-1930PUT0 0151.46FALSE00
2027-02-1940PUT0 098.85FALSE00
2027-02-1950PUT0 083.73FALSE00
2027-02-1960PUT0 069.91FALSE00
2027-02-1970PUT0 063.64FALSE00
2027-02-1981.4PUT0 1070.97FALSE00
2027-02-1990PUT0 071.89TRUE00
2027-02-19100PUT0 062.98TRUE00
2027-02-19110PUT0 060.65TRUE00
2027-02-19120PUT0 059.61TRUE00
2027-02-19130PUT0 054.91TRUE00
2027-02-19140PUT0 00TRUE00
2027-02-19150PUT0 058.06TRUE00
2027-02-19160PUT0 00TRUE00
2027-02-19170PUT0 058.95TRUE00
2028-01-2130CALL0 17482.42TRUE00
2028-01-2154.85CALL0 11574.31TRUE00
2028-01-2180CALL0 26755.13TRUE00
2028-01-21102.4CALL0 150667.44FALSE00
2028-01-21131.75CALL2 26383.13FALSE1.750
2028-01-21150CALL0 28871.35FALSE00
2028-01-21170CALL0 11275.38FALSE00
2028-01-21201CALL0 22181.9FALSE00
2028-01-21220CALL0 14486.17FALSE00
2028-01-21250CALL0 25389.27FALSE00
2028-01-21270CALL0 1993.68FALSE00
2028-01-21300CALL0 3896.71FALSE00
2028-01-21350CALL0 17103.93FALSE00
2028-01-2130PUT0 0280.58FALSE00
2028-01-2150PUT0 0108.83FALSE00
2028-01-2180PUT0 1469.62FALSE00
2028-01-21103PUT0 25752.81TRUE00
2028-01-21130PUT0 17163.96TRUE00
2028-01-21150PUT0 1660.75TRUE00
2028-01-21170PUT0 10058.13TRUE00
2028-01-21200PUT0 461.78TRUE00
2028-01-21220PUT0 10TRUE00
2028-01-21250PUT0 10TRUE00
2028-01-21270PUT0 077.58TRUE00
2028-01-21300PUT0 083.11TRUE00
2028-01-21350PUT0 091.24TRUE00

Latest ADMA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST38$1.905
Jun 13, 2022 7:59 PM EST100$1.905
Jun 13, 2022 7:59 PM EST100$1.905
Jun 13, 2022 7:59 PM EST36$1.905
Jun 13, 2022 7:59 PM EST100$1.9

ADMA Biologics, Inc (ADMA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2019-10-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1368514/000000000019014431/0000000000-19-014431-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000083423720008032/0000834237-20-008032-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000083423720009209/0000834237-20-009209-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000091957419001192/0000919574-19-001192-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000091957420001141/0000919574-20-001141-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000108514619000734/0001085146-19-000734-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000108514620000752/0001085146-20-000752-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2019-06-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1368514/000112329219000869/0001123292-19-000869-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000114036120010160/0001140361-20-010160-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1368514/000114036120010161/0001140361-20-010161-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312519040961/0001193125-19-040961-index.htm
2019-05-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312519154707/0001193125-19-154707-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312520038101/0001193125-20-038101-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001175/0001193805-18-001175-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001198/0001193805-18-001198-index.htm
2018-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001210/0001193805-18-001210-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001238/0001193805-18-001238-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001316/0001193805-18-001316-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380518001319/0001193805-18-001319-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001425/0001193805-18-001425-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001429/0001193805-18-001429-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001431/0001193805-18-001431-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000012/0001193805-19-000012-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000026/0001193805-19-000026-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000090/0001193805-19-000090-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000091/0001193805-19-000091-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000092/0001193805-19-000092-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000098/0001193805-19-000098-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000160/0001193805-19-000160-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000246/0001193805-19-000246-index.htm
2019-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000251/0001193805-19-000251-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000254/0001193805-19-000254-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000280/0001193805-19-000280-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000281/0001193805-19-000281-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000292/0001193805-19-000292-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000293/0001193805-19-000293-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000294/0001193805-19-000294-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000295/0001193805-19-000295-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000296/0001193805-19-000296-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000297/0001193805-19-000297-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000301/0001193805-19-000301-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000332/0001193805-19-000332-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000339/0001193805-19-000339-index.htm
2019-04-05PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000346/0001193805-19-000346-index.htm
2019-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000366/0001193805-19-000366-index.htm
2019-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000415/0001193805-19-000415-index.htm
2019-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000441/0001193805-19-000441-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000454/0001193805-19-000454-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000455/0001193805-19-000455-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000470/0001193805-19-000470-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000490/0001193805-19-000490-index.htm
2019-05-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000492/0001193805-19-000492-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000496/0001193805-19-000496-index.htm
2019-05-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000498/0001193805-19-000498-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000525/0001193805-19-000525-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000540/0001193805-19-000540-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000559/0001193805-19-000559-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000561/0001193805-19-000561-index.htm
2019-06-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000569/0001193805-19-000569-index.htm
2019-07-01PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000614/0001193805-19-000614-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000621/0001193805-19-000621-index.htm
2019-07-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000637/0001193805-19-000637-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000714/0001193805-19-000714-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000715/0001193805-19-000715-index.htm
2019-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000761/0001193805-19-000761-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000774/0001193805-19-000774-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000798/0001193805-19-000798-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000839/0001193805-19-000839-index.htm
2019-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000887/0001193805-19-000887-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000893/0001193805-19-000893-index.htm
2019-10-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1368514/000119380519000903/0001193805-19-000903-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000905/0001193805-19-000905-index.htm
2019-10-07424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000907/0001193805-19-000907-index.htm
2019-10-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001327/0001193805-19-001327-index.htm
2019-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001351/0001193805-19-001351-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001355/0001193805-19-001355-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001361/0001193805-19-001361-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001396/0001193805-19-001396-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519001398/0001193805-19-001398-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001423/0001193805-19-001423-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001461/0001193805-19-001461-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001941/0001193805-19-001941-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000010/0001193805-20-000010-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000024/0001193805-20-000024-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000033/0001193805-20-000033-index.htm
2020-02-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000106/0001193805-20-000106-index.htm
2020-02-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000109/0001193805-20-000109-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000110/0001193805-20-000110-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000138/0001193805-20-000138-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000139/0001193805-20-000139-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000259/0001193805-20-000259-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000300/0001193805-20-000300-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000348/0001193805-20-000348-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000349/0001193805-20-000349-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000377/0001193805-20-000377-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000452/0001193805-20-000452-index.htm
2020-04-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000474/0001193805-20-000474-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000502/0001193805-20-000502-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000529/0001193805-20-000529-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000548/0001193805-20-000548-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000549/0001193805-20-000549-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000550/0001193805-20-000550-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000551/0001193805-20-000551-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000552/0001193805-20-000552-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000553/0001193805-20-000553-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000561/0001193805-20-000561-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000562/0001193805-20-000562-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000618/0001193805-20-000618-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000638/0001193805-20-000638-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000710/0001193805-20-000710-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000712/0001193805-20-000712-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000770/0001193805-20-000770-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000957/0001193805-20-000957-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000960/0001193805-20-000960-index.htm
2020-08-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000961/0001193805-20-000961-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001111/0001193805-20-001111-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001390/0001193805-20-001390-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520001392/0001193805-20-001392-index.htm
2020-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520001393/0001193805-20-001393-index.htm
2019-10-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1368514/999999999519002318/9999999995-19-002318-index.htm
2018-09-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1368514/999999999718008174/9999999997-18-008174-index.htm
2019-04-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1368514/999999999719002962/9999999997-19-002962-index.htm
2020-02-03SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1368514/999999999720000431/9999999997-20-000431-index.htm
2020-02-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1368514/999999999720000623/9999999997-20-000623-index.htm

ADMA Biologics, Inc (ADMA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ADMA Biologics, Inc (ADMA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 213%
Institutional Ownership: 5451%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-17Jerrold B GrossmanDirectorBuy12,000.004.0048,000.00110,007.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-21PERCEPTIVE ADVISORS LLC10% Share HolderBuy4,000,000.004.0016,000,000.0011,521,102.00https://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-11Jerrold B GrossmanDirectorBuy22,857.003.5079,999.50132,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-28Jerrold B GrossmanDirectorBuy7,500.00140,364.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy200.002.87574.00140,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy5,000.002.8914,450.00145,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy5,000.002.9014,475.00150,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-21Jerrold B GrossmanDirectorBuy5,000.002.5612,800.00155,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-08-21Jerrold B GrossmanDirectorBuy300.002.62786.00155,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-02-11PERCEPTIVE ADVISORS LLC10% Share HolderBuy4,563,700.003.5015,972,950.0016,084,802.00https://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-09-10Jerrold B GrossmanDirectorBuy5,000.002.2211,100.00160,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-03-19PERCEPTIVE ADVISORS LLC10% Share HolderBuy500,000.002.101,050,000.0016,584,802.00https://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2020-02-28Adam S GrossmanPresident and CEOBuy100,000.00166,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy10.003.0630.60166,108.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy2,990.003.079,179.30169,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy2,000.003.046,080.00171,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-11Adam S GrossmanPresident and CEOBuy1,000.002.972,970.00172,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-09-08Adam S GrossmanPresident and CEOBuy4,000.002.248,959.60176,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2019-05-17James MondEVP, CSO and CMOBuy4,500.004.0018,000.0017,889.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2020-08-13MARTHA J DEMSKIDirectorBuy2,000.002.885,760.002,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-02-11James MondCSO and CMOBuy4,285.003.5014,997.5022,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-11Jerrold B GrossmanDirectorBuy22,857.003.5079,999.5022,857.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2019-05-17BRIAN LENZEVP, CFOBuy5,000.004.0020,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2020-02-11BRIAN LENZEVP, CFOBuy7,142.003.5024,997.0032,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2019-05-17Adam S GrossmanPresident and CEOBuy5,000.004.0020,000.0037,527.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-09-11MARTHA J DEMSKIDirectorBuy2,200.002.295,038.004,200.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2019-06-06Biotest Divestiture Trust10% Share HolderSell5,813,954.003.7521,802,327.504,295,580.00https://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2020-02-28ERIC I RICHMANDirectorBuy7,500.0044,030.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2019-05-17Lawrence P. GuiheenDirectorBuy25,000.004.00100,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2020-02-28James MondEVP, CSO and CMOBuy40,000.0062,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-02-11Adam S GrossmanPresident and CEOBuy28,571.003.5099,998.5066,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-08-10James MondEVP, CSO and CMOBuy5,000.002.8814,400.0067,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-10James MondEVP, CSO and CMOBuy2,000.002.885,750.0069,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-02-11Lawrence P. GuiheenDirectorBuy20,000.003.5070,000.0070,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-28BRIAN LENZEVP, CFOBuy40,000.0072,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-09-08James MondEVP, CSO and CMOBuy4,000.002.208,800.0073,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-02-28Bryant FongDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-02-28DOV A MD GOLDSTEINDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-02-28STEVE ELMSDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-08-11BRIAN LENZEVP, CFOBuy4,000.002.9711,860.0076,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-02-28Lawrence P. GuiheenDirectorBuy7,500.0077,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2019-05-17Adam S GrossmanPresident and CEOBuy25,000.004.00100,000.00821,301.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-02-11Adam S GrossmanPresident and CEOBuy57,143.003.50200,000.50878,444.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm